Global Phosphoramidite Market is Anticipated to Witness High Growth Owing to Wide Application in Synthetic Biology
Phosphoramidite Market |
The global phosphoramidite market is primarily driven by its wide application in synthetic biology. Phosphoramidites are primarily used in DNA synthesis for producing oligonucleotides and other synthetic DNA or RNA fragments through the phosphoramidite method. They are preferred as intermediates in solid phase oligonucleotide synthesis due to properties like ability to protect phosphorus moieties during oligonucleotide assembly procedures. Apart from DNA synthesis, phosphoramidites also find applications in polymerase chain reaction (PCR), targeted genome engineering methods like CRISPR and generation of DNA/RNA aptamers that are used for biosensing and targeted drug delivery applications.
The Global phosphoramidite market is
estimated to be valued at US$ 1,011.3 MN in 2024 and is expected to exhibit a
CAGR of 7.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global phosphoramidite market are Glen Research,
ChemGenes Corporation, Link Technologies Ltd., BioAutomation Corporation, Merck
KGaA, Sigma-Aldrich (now part of MilliporeSigma, a Merck Group company), LGC
Biosearch Technologies, Thermo Fisher Scientific, Biosynthesis Inc., ATDBio
Ltd., Genscript Biotech Corporation, Expedeon AG, Wuxi Donglin Sci & Tech
Development Co., Ltd., Bio-Synthesis Inc., and ChemGenes Corporation. Some of
these companies are focusing on inorganic growth strategies like acquisitions
and collaborations to expand their product portfolio and market presence.
The Phosphoramidite
Market Demand is expected to witness lucrative opportunities due to
growing applications of synthetic oligonucleotides. Advances in fields like
genomics, drug discovery and synthetic biology have increased demand for
high-quality oligonucleotides synthesized using phosphoramidites as starting
materials. This is expected to drive market revenue growth over the forecast
period.
North America dominated the global market in 2022 due to well-established
pharmaceutical and biotechnology industries and growing adoption of synthetic
biology in the region. However, Asia Pacific is expected to witness highest
growth during the forecast period owing to increasing investments by key market
players, advancing research infrastructure and growing biotechnology industry
in the region.
Market Drivers
- Rising adoption of synthetic biology techniques for therapeutics development,
industrial applications and genomic research is a major factor driving market
growth. Phosphoramidites play a vital role as starting materials in large-scale
oligonucleotide synthesis.
- Growing field of DNA nanotechnology and development of advanced applications
like programmable assemblies of synthetic DNA and RNA for nanomaterials, drug
delivery and biosensing is also fueling demand.
Market Restraints
- Availability of alternative oligonucleotide synthesis techniques restricting
complete dependence on phosphoramidite chemistry.
- High costs associated with phosphoramidite monomers and solid-phase DNA
synthesis equipment hampering market growth in cost-sensitive regions.
Comments
Post a Comment